By Route of Administration: Parenteral dominates, Oral growing fastest Parenteral (subcutaneous injection) delivery held the dominant route of administration position in 2025, reflecting that all high-dose, high-efficacy GLP-1 formulations currently approved for obesity management require injection for the delivery of drug quantities sufficient to achieve therapeutic plasma concentrations
The therapies, however, do not cure lipedema and only bring about a small reduction in tissue volume, as it has been observed that lipedema tissue resists changes in diet and exercise (Mazarei et al., 2025)
10.1039/d5tb00487j 173 MoovskS.PetkovP.KalikM.MikulajovaA
While it is generally considered safe, it is essential to consult with a healthcare provider before starting any new supplementation regimen
It comes down to results, side effects, and affordability
Recommended for individuals with absorption issues and severe deficiencies, B12 injections are considered more effective because they bypass the digestive tract and deliver the vitamin directly into the bloodstream